122 related articles for article (PubMed ID: 38518525)
1. Discovery of novel polyheterocyclic neuraminidase inhibitors with 1,3,4-oxadiazole thioetheramide as core backbone.
Shang LL; Zhong ZJ; Cheng LP
Eur J Med Chem; 2024 Apr; 269():116305. PubMed ID: 38518525
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Boron-Containing
Jia R; Zhang J; Zhang J; Bertagnin C; Bonomini A; Guizzo L; Gao Z; Ji X; Li Z; Liu C; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234966
[TBL] [Abstract][Full Text] [Related]
3. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
[TBL] [Abstract][Full Text] [Related]
4. Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties.
Jia R; Zhang J; Shi F; Bonomini A; Lucca C; Bertagnin C; Zhang J; Liu C; Jia H; Jiang Y; Ma X; Loregian A; Huang B; Zhan P; Liu X
Eur J Med Chem; 2023 Apr; 252():115275. PubMed ID: 36931117
[TBL] [Abstract][Full Text] [Related]
5. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
Jia R; Zhang J; Ai W; Ding X; Desta S; Sun L; Sun Z; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2019 Sep; 178():64-80. PubMed ID: 31176096
[TBL] [Abstract][Full Text] [Related]
7. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
Fu SK; Cheng LP
Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962
[TBL] [Abstract][Full Text] [Related]
8. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
Yu W; Ping Cheng L; Pang W; Ling Guo L
Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
[TBL] [Abstract][Full Text] [Related]
11. Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors
Ju H; Hou L; Zhao F; Zhang Y; Jia R; Guizzo L; Bonomini A; Zhang J; Gao Z; Liang R; Bertagnin C; Kong X; Ma X; Kang D; Loregian A; Huang B; Liu X; Zhan P
J Med Chem; 2022 Sep; 65(17):11550-11573. PubMed ID: 35939763
[TBL] [Abstract][Full Text] [Related]
12. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of
Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of NH
Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
[TBL] [Abstract][Full Text] [Related]
16. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
Ilyushina NA; Seiler JP; Rehg JE; Webster RG; Govorkova EA
PLoS Pathog; 2010 May; 6(5):e1000933. PubMed ID: 20523902
[TBL] [Abstract][Full Text] [Related]
17. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y
J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors.
Wang B; Wang K; Meng P; Hu Y; Yang F; Liu K; Lei Z; Chen B; Tian Y
Bioorg Med Chem Lett; 2018 Nov; 28(21):3477-3482. PubMed ID: 30266543
[TBL] [Abstract][Full Text] [Related]
20. A novel
Zhang J; Liu C; Jia R; Zhang X; Zhang J; Bertagnin C; Bonomini A; Guizzo L; Jiang Y; Jia H; Jia S; Ma X; Loregian A; Huang B; Zhan P; Liu X
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2277135. PubMed ID: 37955306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
